Full text
PDFPage 1507
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Byrne E. J., Arie T. Tetrahydroaminoacridine and Alzheimer's disease. BMJ. 1994 Apr 2;308(6933):868–869. doi: 10.1136/bmj.308.6933.868. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Farlow M., Gracon S. I., Hershey L. A., Lewis K. W., Sadowsky C. H., Dolan-Ureno J. A controlled trial of tacrine in Alzheimer's disease. The Tacrine Study Group. JAMA. 1992 Nov 11;268(18):2523–2529. [PubMed] [Google Scholar]
- Knapp M. J., Knopman D. S., Solomon P. R., Pendlebury W. W., Davis C. S., Gracon S. I. A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. The Tacrine Study Group. JAMA. 1994 Apr 6;271(13):985–991. [PubMed] [Google Scholar]
- Maltby N., Broe G. A., Creasey H., Jorm A. F., Christensen H., Brooks W. S. Efficacy of tacrine and lecithin in mild to moderate Alzheimer's disease: double blind trial. BMJ. 1994 Apr 2;308(6933):879–883. doi: 10.1136/bmj.308.6933.879. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wilcock G. K., Surmon D. J., Scott M., Boyle M., Mulligan K., Neubauer K. A., O'Neill D., Royston V. H. An evaluation of the efficacy and safety of tetrahydroaminoacridine (THA) without lecithin in the treatment of Alzheimer's disease. Age Ageing. 1993 Sep;22(5):316–324. doi: 10.1093/ageing/22.5.316. [DOI] [PubMed] [Google Scholar]